Clinician perspectives on preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies.

被引：0

作者：

Lau-Min, Kelsey S. ^{[1
]}

Varughese, Lisa A. ^{[2
]}

Nelson, Maria N. ^{[3
]}

Cambareri, Christine ^{[4
]}

Reddy, Nandi J. ^{[5
]}

Oyer, Randall A. ^{[5
]}

Teitelbaum, Ursina R. ^{[1
]}

Tuteja, Sony ^{[2
]}

机构：

[1] Univ Penn, Dept Med, Div Hematol Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA

[2] Univ Penn, Dept Med, Div Translat Med & Human Genet, Perelman Sch Med, Philadelphia, PA 19104 USA

[3] Univ Penn, Perelman Sch Med, Dept Family Med & Community Hlth, Mixed Methods Res Lab, Philadelphia, PA 19104 USA

[4] Hosp Univ Penn, Dept Pharm, 3400 Spruce St, Philadelphia, PA 19104 USA

[5] Penn Med Lancaster Gen Hlth, Ann B Barshinger Canc Inst, Lancaster, PA USA

来源：

关键词：

D O I：

10.1200/JCO.2021.39.3_suppl.54

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：3